Enter assignee name

% Expired Patents = 25.0

EPO Patents = 3

Trademarks = 25

Forward Citations = 33

Loading Chart...

9 inventors (with patents filed for the assignee):

Ashim K Mitra (3 out of 18 patents)

Poonam R Velagaleti (3 out of 6 patents)

Selvaraj A Naicker (3 out of 28 patents)

4. Randall W Yatscoff (3 out of 33 patents)

5. Robert T Foster (3 out of 37 patents)

6. Subramanian Natesan (2 out of 4 patents)

7. Neil Solomons (2 out of 2 patents)

8. Robert B Huizinga (2 out of 2 patents)

9. Ulrich M Grau (1 out of 1 patent)

10. Poonam R Valagaleti (0 patent)

8 patents: Sort by Forward Citations

1. 11622991 - Protocol for treatment of lupus nephritis (2023-04-11),

2. 10973871 - Ophthalmic compositions (2021-04-13),

3. RE48226 - Cyclosporine analogue mixtures and their use as immunomodulating agents (2020-09-28),

4. 10472394 - Cyclosporine analogue mixtures and their use as immunomodulating agents (2019-11-12),

5. 10286036 - Protocol for treatment of lupus nephritis (2019-05-14),

6. 10265375 - Ophthalmic compositions (2019-04-23),

7. 9765119 - Cyclosporine analogue mixtures and their use as immunomodulating agents (2017-09-19),

8. 9017725 - Topical drug delivery systems for ophthalmic use (2015-04-28),

Aurinia Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat rare autoimmune diseases. The company's lead product candidate, voclosporin, is being evaluated in multiple clinical trials for the treatment of lupus nephritis and other autoimmune diseases. Aurinia is committed to improving the lives of patients through innovative drug development.

Profile summary based on public USPTO records.